Search Results
Search for other papers by Hui-qing Yuan in
Google Scholar
PubMed
Search for other papers by Jia-xi Miao in
Google Scholar
PubMed
Search for other papers by Jia-ping Xu in
Google Scholar
PubMed
Search for other papers by Su-xiang Zhu in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Xiao-hua Wang in
Google Scholar
PubMed
Search for other papers by Chun-hua Wang in
Google Scholar
PubMed
Search for other papers by Chao Yu in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed
increased insulin secretion from β-cells. It is widely accepted that the pathogenesis of insulin resistance is involved with ectopic lipid accumulation and systemic inflammation ( 42 ). CysC mRNA expression and CysC release by subcutaneous and omental
Search for other papers by Antonia Ertelt in
Google Scholar
PubMed
Search for other papers by Ann-Kristin Barton in
Google Scholar
PubMed
Search for other papers by Robert R Schmitz in
Google Scholar
PubMed
Search for other papers by Heidrun Gehlen in
Google Scholar
PubMed
accelerated lipolysis and an increased amount of free fatty acids in the bloodstream (84) . Inflammation of adipose tissue induces production of proinflammatory adipokines that increase their own synthesis and synthesis of other systemic inflammatory markers
Search for other papers by Estíbaliz Castillero in
Google Scholar
PubMed
Search for other papers by Ana Isabel Martín in
Google Scholar
PubMed
Search for other papers by Maria Paz Nieto-Bona in
Google Scholar
PubMed
Search for other papers by Carmen Fernández-Galaz in
Google Scholar
PubMed
Search for other papers by María López-Menduiña in
Google Scholar
PubMed
Search for other papers by María Ángeles Villanúa in
Google Scholar
PubMed
Search for other papers by Asunción López-Calderón in
Google Scholar
PubMed
addition to inflammatory mediators, dysregulation of metabolism is an important contributor to inflammatory cachexia (2) . Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that modulate metabolism and inflammation
AESKU.KIPP Institute, Wendelsheim, Germany
Search for other papers by Aaron Lerner in
Google Scholar
PubMed
Search for other papers by Patricia Jeremias in
Google Scholar
PubMed
Search for other papers by Torsten Matthias in
Google Scholar
PubMed
posttranslational modification of the absorbed gliadin peptide, deamidating or crosslinking, those peptides are becoming immunogenic/toxic, resulting in mucosal inflammation and damage. Several well established serological markers are available for the diagnosis and
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Xiao-qin Ge in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
always precede renal function decline ( 6 ). A diagnosis of DKD depending on albuminuria may delay the diagnosis and treatment of some patients with DKD. Therefore, there is an urgent need to seek new therapeutic targets and diagnostic markers for DKD
Search for other papers by Bharat Kumar in
Google Scholar
PubMed
Search for other papers by Madhukar Mittal in
Google Scholar
PubMed
Search for other papers by Maya Gopalakrishnan in
Google Scholar
PubMed
Search for other papers by Mahendra K Garg in
Google Scholar
PubMed
Search for other papers by Sanjeev Misra in
Google Scholar
PubMed
associated with a higher mortality and were strongly correlated with markers of inflammation (including hs-CRP and IL6). There was an increase in hazard ratio for mortality with every 100 mg/dL increase in plasma glucose level. Patients admitted with plasma
Search for other papers by Nancy Martini in
Google Scholar
PubMed
Search for other papers by Lucas Streckwall in
Google Scholar
PubMed
Search for other papers by Antonio Desmond McCarthy in
Google Scholar
PubMed
permeability of these atheroprone areas. Hyperlipidaemia and biomechanical stress acting on the endothelial cell cause activation of the NFKB pathway with the consequent expression of inflammation marker molecules such as VCAM1, ICAM1, E selectin and TLR2 on
Institute of Nutritional Science, University of Potsdam, Potsdam, Germany
Search for other papers by Liselot Koelman in
Google Scholar
PubMed
Department of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany
Search for other papers by Robin Reichmann in
Google Scholar
PubMed
Search for other papers by Claudia Börnhorst in
Google Scholar
PubMed
Institute of Nutritional Science, University of Potsdam, Potsdam, Germany
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Matthias B Schulze in
Google Scholar
PubMed
Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany
Search for other papers by Cornelia Weikert in
Google Scholar
PubMed
Search for other papers by Ronald Biemann in
Google Scholar
PubMed
Search for other papers by Berend Isermann in
Google Scholar
PubMed
Search for other papers by Andreas Fritsche in
Google Scholar
PubMed
Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany
Search for other papers by Krasimira Aleksandrova in
Google Scholar
PubMed
other inflammation markers such as CRP as shown in our data. However, CRP is a non-specific biomarker of inflammation and may also reflect obesity-associated inflammatory phenotype. Indeed, the enlarged adipose tissue is one important source of secretion
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Cornelia Then in
Google Scholar
PubMed
Search for other papers by Holger Then in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Andreas Lechner in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
Search for other papers by Cornelia Huth in
Google Scholar
PubMed
Chair of Epidemiology at UNIKAT Augsburg, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Christa Meisinger in
Google Scholar
PubMed
KORA Study Center, University Hospital Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
Search for other papers by Wolfgang Rathmann in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christian Herder in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Michael Roden in
Google Scholar
PubMed
Search for other papers by Jürgen Scherberich in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Jochen Seissler in
Google Scholar
PubMed
settings, indicating the presence of relevant systemic effects ( 22 , 23 , 24 ). Since obesity and metabolic syndrome are associated with low-grade inflammation, immunomodulatory sUmod properties might positively influence metabolism in this condition
School of Nursing, Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, UK
Search for other papers by Jane Fletcher in
Google Scholar
PubMed
Search for other papers by Emma L Bishop in
Google Scholar
PubMed
Search for other papers by Stephanie R Harrison in
Google Scholar
PubMed
Search for other papers by Amelia Swift in
Google Scholar
PubMed
Search for other papers by Sheldon C Cooper in
Google Scholar
PubMed
Search for other papers by Sarah K Dimeloe in
Google Scholar
PubMed
Search for other papers by Karim Raza in
Google Scholar
PubMed
Search for other papers by Martin Hewison in
Google Scholar
PubMed
synovial inflammation is not driving systemic spill-over of any immune cell-derived 1,25D ( 67 ). In other autoimmune disorders such as MS, serum 1,25D concentrations do not appear to be higher in patients vs controls ( 68 ), and have been reported to